Home-Based Heart Failure Rehab Matches Center Programs for Fitness Gains
New trial shows home cardiac rehab with smartwatch monitoring equals traditional center-based programs for heart failure patients.
Cardiovascular disease prevention, blood pressure, cholesterol, and heart function
419 articles
New trial shows home cardiac rehab with smartwatch monitoring equals traditional center-based programs for heart failure patients.
FAME 3 trial finds no difference in death, stroke, or heart attack rates between bypass surgery and stents at 5 years, though stents had more complications.
Machine learning model identifies HFpEF patients 6.3 years before symptom onset with 93% accuracy using integrated clinical and molecular data.
Natural isoflavone prevents cardiac enlargement through novel mitochondrial protection pathway, offering new therapeutic approach.
Breakthrough study shows one epigenetic factor can transform cardiac fibroblasts into heart muscle cells, improving function after myocardial infarction.
New research questions whether intravascular ultrasound is always necessary for evaluating left main coronary artery disease.
Breakthrough discovery of PAK1 kinase activators shows promise for treating cardiac hypertrophy and heart failure through targeted enzyme enhancement.
New research shows inhibiting fatty acid synthase prevents cardiac hypertrophy and restores heart function in multiple models.
Advanced cardiac MRI strain measurements identify diabetic patients at highest risk for heart failure hospitalization and death.
Comprehensive review reveals HRV's potential for early CVD detection, risk prediction, and personalized treatment monitoring.
New research reveals how low oxygen at high altitude triggers vascular damage through metabolic changes, offering therapeutic targets.
Novel liposome therapy delivers miR-10a to atherosclerotic plaques, reprogramming inflammatory macrophages and reducing disease progression in mice.